atorvastatin has been researched along with Tachycardia, Ventricular in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Hu, X; Li, C | 1 |
| Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ | 1 |
| Cheng, W; Hu, H; Li, X; Shi, Y; Wang, Y; Xuan, Y; Xue, M; Yan, S; Yang, N; Yin, J | 1 |
| He, XZ; Wan, XH; Wang, HY; Xue, JF; Zhong, QH; Zhou, SH | 2 |
| Chedgy, F; Howlett, DC; Inglis, C | 1 |
| Bernard, D; De Backer, G; De Bacquer, D; De Buyzere, M; De Sutter, J; Jordaens, L; Langlois, M; Matthys, K; Tavernier, R; Van de Veire, NR | 1 |
5 trial(s) available for atorvastatin and Tachycardia, Ventricular
| Article | Year |
|---|---|
Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.
Topics: Anticholesteremic Agents; Atorvastatin; Cohort Studies; Electrocardiography; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Rosuvastatin Calcium; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left | 2018 |
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc
Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria | 2014 |
The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Chi-Square Distribution; China; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk Assessment; Risk Factors; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes | 2010 |
The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Anti-Arrhythmia Agents; Atorvastatin; Chi-Square Distribution; China; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk Assessment; Risk Factors; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes | 2011 |
Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Belgium; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Greece; Heptanoic Acids; Humans; Inflammation; Inflammation Mediators; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prevalence; Pyrroles; Research Design; Risk Factors; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2006 |
2 other study(ies) available for atorvastatin and Tachycardia, Ventricular
| Article | Year |
|---|---|
Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Arginase; Atorvastatin; Cells, Cultured; Disease Models, Animal; GAP-43 Protein; Heart; Interleukin-1beta; Macrophage Activation; Macrophages, Peritoneal; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Nitric Oxide Synthase Type II; Phenotype; Rats, Wistar; Sympathetic Nervous System; Tachycardia, Ventricular; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Ventricular Fibrillation | 2016 |
A case of recurrent ventricular tachycardia.
Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin | 2011 |